logo

For the Inventor, By the Inventor

Jin Kim Montclare

New York, NY, United States of America

Jin Kim Montclare

LinkedIn

This inventor holds 10 USPTO granted patents and 4 published patent applications. Top assignee: New York University. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jin Kim Montclare. Retrieved from https://idiyas.com/inventor/jin-kim-montclare

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 80.0

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:

goldMedal10 out of 1,728 
 
New York University
 patents

Years Active: 2014-2024

Loading Chart...
10 patents (USPTO):Explore Patents
1. 11892449 - Therapeutics and point of care lateral-flow test for virus and antibodies using tagged assembled proteins (2024-02-06),
2. 10463752 - Protein polymer gold nanoparticle hybrid materials for small molecule delivery (2019-11-05),
3. 10376603 - Engineered fluorinated biomaterials (2019-08-13),
4. 9777041 - Protein nanofibers from self-assembling pentamers (2017-10-03),
5. 9617525 - Phosphotriesterase enzymes, methods and compositions related thereto (2017-04-11),
6. 9554997 - Polymer carrier (2017-01-31),
7. 9453060 - Protein engineered systems for delivery of molecules (2016-09-27),
8. 9370491 - Polymer carrier (2016-06-21),
9. 9359408 - Fluorinated protein-based polymeric carriers (2016-06-07),
10. 8790709 - Polymer Carrier (2014-07-29),

Title: Innovations of Jin Kim Montclare

Introduction

Jin Kim Montclare is a prominent inventor based in New York, NY, known for her significant contributions to the field of biotechnology. With a total of 10 patents to her name, she has made remarkable advancements in therapeutic solutions and diagnostic testing.

Latest Patents

Among her latest patents is a groundbreaking therapeutic and point-of-care lateral-flow test for viruses and antibodies using tagged assembled proteins. This innovation provides a multivalent protein that targets the interaction of the SARS-CoV-2 spike receptor binding domain (RBD) with the human angiotensin-converting enzyme 2 (ACE2) receptor protein. The multivalent proteins may also be utilized to treat subjects suffering from cancer, diseases, or viral infections. Additionally, she has developed multiplex lateral flow test strips for the simultaneous detection of the virus and viral antibodies. Another notable patent involves protein polymer-gold nanoparticle hybrid materials for small molecule delivery. This invention comprises a gold core and a plurality of protein polymer molecules coordinated to the gold core via a poly-histidine tag present on each protein polymer molecule. These protein polymer-gold nanoparticles can be employed in methods of small molecule delivery to individuals.

Career Highlights

Jin Kim Montclare is affiliated with New York University, where she continues to push the boundaries of scientific research and innovation. Her work has garnered attention for its potential impact on public health and disease management.

Collaborations

She collaborates with esteemed colleagues such as Carlo Yuvienco and Joseph Frezzo, contributing to a dynamic research environment that fosters innovation.

Conclusion

Jin Kim Montclare's contributions to biotechnology through her patents and research at New York University highlight her role as a leading inventor in the field. Her work not only advances scientific knowledge but also has the potential to improve health outcomes for many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…